These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16235799)

  • 1. [Diagnostic image (248). A girl with swollen cheeks].
    Brand PL
    Ned Tijdschr Geneeskd; 2005 Oct; 149(40):2221. PubMed ID: 16235799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mumps in Poland in 2006].
    Stefanoff P; Rogalska J
    Przegl Epidemiol; 2008; 62(2):225-8. PubMed ID: 18807461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mumps in Poland in 2003].
    Rosińska M
    Przegl Epidemiol; 2005; 59(2):209-13. PubMed ID: 16190522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mumps resurgence prompts revised recommendations.
    Miller C
    Minn Med; 2007 Feb; 90(2):41-3. PubMed ID: 17388260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mumps in Poland in 2005].
    Stefanoff P
    Przegl Epidemiol; 2007; 61(2):195-8. PubMed ID: 17956031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mumps in Poland in 2007].
    Paradowska-Stankiewicz I; Orlíková H; Rudowska J
    Przegl Epidemiol; 2009; 63(2):173-5. PubMed ID: 19799239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [History of mumps].
    Gerardy KF
    MMW Fortschr Med; 2007 Aug; 149(33-34):53. PubMed ID: 17912869
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.
    Castilla J; García Cenoz M; Arriazu M; Fernández-Alonso M; Martínez-Artola V; Etxeberria J; Irisarri F; Barricarte A
    Vaccine; 2009 Mar; 27(15):2089-93. PubMed ID: 19356610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory diagnosis of parotitis in the post-vaccination era].
    de la Loma A; Villota J; Varela JM; Alonso M; de Ory F
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):119-20. PubMed ID: 12586040
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemics in vaccinated persons. Do adults need a mumps booster vaccination? (interview by Dr. Judith Neumaier)].
    Mankertz A
    MMW Fortschr Med; 2008 Jun; 150(23):7. PubMed ID: 18578069
    [No Abstract]   [Full Text] [Related]  

  • 13. MMR vaccination: new thought.
    Deshmukh V
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-preventable mumps outbreaks in schoolchildren in Catalonia.
    Cardeñosa N; Domínguez A; Camps N; Martínez A; Torner N; Navas E; Salleras L
    Scand J Infect Dis; 2006; 38(8):671-4. PubMed ID: 16857613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mumps outbreak that wasn't.
    Guy R; Leydon J; Andrews R; Lambert S
    Aust N Z J Public Health; 2002 Apr; 26(2):180-1. PubMed ID: 12054340
    [No Abstract]   [Full Text] [Related]  

  • 16. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mumps--still actual epidemiological problem in Poland].
    Pogorzelska M; Ołdak E; Sulik A
    Przegl Epidemiol; 2005; 59(4):841-9. PubMed ID: 16729425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N; Jansson UB; Alm B
    Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.